🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Clorox expands board with two new directors

Published 2024-11-20, 04:40 p/m
CLX
-

OAKLAND - The Clorox Company (NYSE: NYSE:CLX) announced the addition of Stephen Bratspies and Pierre Breber to its board of directors, effective today. The appointments of Bratspies and Breber are part of Clorox's strategic efforts to enhance its leadership and growth.

Stephen Bratspies, 57, is recognized for his executive leadership as CEO of Hanesbrands (NYSE:HBI) and his extensive experience in operational, merchandising, and marketing roles at Walmart (NYSE:WMT), Specialty Brands, and PepsiCo (NASDAQ:PEP). His background in customer, retail, and consumer packaged goods industries is expected to provide valuable insights into Clorox's strategy and business development. Bratspies also maintains a position on the Board of Hanesbrands.

Pierre Breber, 60, brings a wealth of financial and accounting knowledge from his tenure as CFO at Chevron (NYSE:CVX), along with a history of executive, commercial, operational, and international roles. His expertise in strategic transformation and growth initiatives aligns with Clorox's objectives. Breber currently serves on the Boards of PACCAR (NASDAQ:PCAR) and Southwest Airlines (NYSE:LUV).

Linda Rendle, chair and CEO of The Clorox Company, expressed honor in welcoming the two new members, citing their "exceptional experience" and the value of their "fresh perspectives and deep backgrounds" in supporting Clorox's pursuit of long-term value creation.

With the new appointments, Bratspies is set to join the Audit committee, while Breber will participate in both the Audit and the Nominating, Governance, and Corporate Responsibility committees. The recent changes follow the non-re-election of Amy Banse, Paul Parker, and Kathryn Tesija at the annual stockholders' meeting. The board now consists of 11 members.

The Clorox Company, known for its portfolio of brands including Brita, Burt's Bees, and Pine-Sol, has been a proponent of integrating Environmental, Social, and Governance (ESG) criteria into its business practices. In 2024, Clorox was recognized for its sustainability efforts, ranking first on Barron's 100 Most Sustainable Companies list for the second year in a row.

The information in this article is based on a press release statement from The Clorox Company.

In other recent news, Clorox announced a quarterly dividend of $1.22 per share, reflecting the company's financial health and commitment to shareholder value. The company also reported strong first-quarter earnings for fiscal year 2025, outperforming expectations with a substantial earnings per share beat and a robust 31% growth in organic sales. Analysts from TD (TSX:TD) Cowen, DA Davidson, and Jefferies have adjusted their stance on Clorox, with TD Cowen upgrading the stock from Sell to Hold and DA Davidson increasing Clorox's price target to $171.00. Despite a strong first quarter, Clorox projects a low-teens sales decrease for the second quarter due to volume pull-forward, but anticipates organic growth between 3% to 5% for the second half of the year. These recent developments reflect the company's ongoing efforts to navigate the competitive landscape and deliver value to its investors.

InvestingPro Insights

The recent board appointments at The Clorox Company (NYSE: CLX) come at a time when the company is showing strong financial performance and market positioning. According to InvestingPro data, Clorox has a market capitalization of $20.8 billion and is trading near its 52-week high, with a significant price uptick of 26.74% over the last six months.

Clorox's commitment to shareholder value is evident in its dividend history. An InvestingPro Tip highlights that the company has raised its dividend for 48 consecutive years, demonstrating a strong track record of returning value to shareholders. This consistency aligns with the company's focus on long-term value creation, as mentioned by CEO Linda Rendle.

The company's financial health appears robust, with revenue growth of 6.17% over the last twelve months and a strong EBITDA growth of 42.81% in the same period. These figures suggest that Clorox's strategic initiatives, which the new board members are expected to support, are yielding positive results.

However, investors should note that Clorox is trading at a high P/E ratio of 58.28, which may indicate that the stock is priced at a premium. This valuation metric could be an important consideration for the newly appointed board members as they contribute to the company's growth strategies.

For those interested in a deeper analysis, InvestingPro offers 12 additional tips for Clorox, providing a more comprehensive view of the company's financial position and market outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.